Exocrinopathy in the CD1 et/et hypothymic mouse resembling Sjögren syndrome

Main Article Content

MARÍA DE LOS ÁNGELES LARA HERNÁNDEZ
RICARDO CALVILLO ESPARZA
MARTHA MERCEDES GARCÍA BURCIAGA
RUBÉN MARROQUIN SEGURA
MARÍA EUGENIA CASTRO MUSSAT
JOSÉ LUÍS ALFREDO MORA GUEVARA
MAURILIO FLORES PIMENTEL

Abstract

LACRIMAL AND SUBMAXILAR GLANDS OF THE NEW NAKED MUTANT MICE KNOWN AS ET/ET WERE COMPARED TO AND HETEROZYGOUS ET/ MICE. RESULTS SHOWED THAT ET/ET MICE PRESENT LOWER GLANDULAR LACRIMAL INDEXES (RELATIVE LACRIMAL GLAND WEIGHTS) THAN MICE (P = 0.0061). IT WAS FOUND THAT ET/ET AND ET/ SHOWED LOWER INDEXES THAN MICE (P = 0.0002) WHEN COMPARING GLANDULAR SUBMAXILAR INDEXES. WHEN ANALYZING THE INFLUENCE OF AGE ON THE GLANDULAR INDEXES IN THE ET/ET MICE, IT WAS FOUND THAT THE MAXIMUM INDEX OF THE LACRIMAL GLANDS OCCURRED AT AN AGE OF AROUND 25 WEEKS, WHILE THE SMALLEST OCCURRED AT AROUND THE 68TH WEEK. IN AS REGARDS AGE AND GLANDULAR SUBMAXILAR INDEXES, IN ET/ET MICE THE MAXIMUM INDEX WAS FOUND IN THE 19TH WEEK, WITH THE LOWEST IN THE 68TH WEEK OF LIFE. THE MALES OF THE ET/ET GROUP PRESENTED HIGHER MEAN GLANDULAR LACRIMAL INDEXES THAN THE FEMALES (10.093 VS 4.558), P = 0.0001, WHEREAS NO SEX DIFFERENCES WERE FOUND IN THE GLANDULAR SUBMAXILAR INDEXES, P = 0.132. WHEN COMPARING ABSOLUTE GLAND WEIGHTS AMONG DIFFERENT ANIMAL GROUPS, THE RESULTS WERE SIMILAR TO THOSE FOUND WHEN USING RELATIVE GLAND WEIGHTS (INDEXES). IN THE HISTOPATHOLOGIC STUDY OF THE ET/ET, ET/ AND GLANDS, THE ET/ET MICE PRESENTED DIFFERENT DEGREES OF LEUCOCYTE INFILTRATION, WHICH WERE MODERATE (COMPRISED MAINLY OF MONOCYTES AND MAINTAINING ARCHITECTURAL DETAIL) AFTER THE 20TH WEEK OF AGE, AND VERY SEVERE (ABUNDANT CELL INFILTRATE AND LOSS OF PARENCHYMA) BY THE 68TH WEEK; WHEREAS ET/ AND ANIMALS DID NOT SHOW INFILTRATED GLANDS AT ANY AGE. THE ET/ET MICE DEVELOPED INFLAMMATORY EXOCRINOPATHY RESEMBLING THAT OF PATIENTS WITH SJÖGREN'S SYNDROME.ET/ET MICE, LACRIMAL GLANDS, SALIVAR
Keywords:
GLANDS EXOCRINOPATHY XEROPHTHALMIA XEROSTOMIA SJÖGREN'S SYNDROME AUTOIMMUNE DISEASE

Article Details